Join Next LSI Event

Join Now

LSI Europe '24 Summit

Filling Fast

Andrew Dahl - BioMEMS Diagnostics, Private Partnering Interview at LSI USA ‘23

Speakers

Andrew Dahl

Andrew Dahl

Founder & Executive Chairman, BioMEMS Diagnostics
BioMEMS Diagnostics has developed a simple-to-use, extremely sensitive and affordable POC testing platform that allows new and esoteric tests to be developed and deployed in months instead of years.

Transcription

Andrew Dahl  0:00  

Hi. I'm Andrew Dahl founder executive chairman of BioMEMS Diagnostics. It's a company that has a breakthrough diagnostic product that allows us to measure pretty much any biomarker in any bio fluid and it brings high needs high complexity diagnostics, to a point of care or at home use, where previously these kinds of tests were not available, were not affordable or practical. We're here at LSI to present our platform technology to the medtech investment community. And our test basically consists of a test cartridge, this handheld analyzer, and a smart device app. And with this cartridge, we can create many different test panels, ranging from concussion to post heart attack, monitoring, healthy aging, many different tests can be developed from this platform. One of the strengths of our platform is not only that we can create many different tests using the same hardware, but that we can also use different bio fluids. So most medical tests are done in blood. We can use saliva, urine, tears, cerebral spinal fluids, simply because our platform is so sensitive, that we can work with some of these other bio fluids where the biomarkers may not be as plentiful as they are in blood. But first small children, for seniors where a blood draw is not very useful, or, or for things that are culturally inappropriate. A non invasive bio fluid is a more efficient way to go. We've gotten a lot of attention for concussion biomarkers. That's really, people have really rallied to that. Because there is nothing right now that works at point of care. In other words, what what can happen courtside or in the ambulance or At the accident scene that can provide some indication of whether there's bleeding on the brain or not, whether there's a severe concussion or not. And that's what we're driving towards with our concussion tests. We're here at LSI basically, to interact with the investment community, and also to look for strategic partners and support sources. You know, everything from executive search to laboratory services. So LSI is a place where that can happen.

 

LSI USA '24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders in Dana Point.

JOIN US TODAY

Share this video

Companies We Work With